Spero Therapeutics Inc (SPRO) — Free Cash Flow Generation Index
Latest as of September 2025:
1.00x
Spero Therapeutics Inc (SPRO) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of $17.42 Million represents 1% of operating cash flow ($17.42 Million). See Spero Therapeutics Inc (SPRO) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
$17.42 Million
USD
Operating Cash Flow
$17.42 Million
USD
Capital Expenditures
$0.00
USD
Annual Free Cash Flow Generation for Spero Therapeutics Inc (None–None)
Year-by-year Free Cash Flow Generation Index for Spero Therapeutics Inc. For the full company profile including market capitalisation, see how much is Spero Therapeutics Inc worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).